ABA Chemicals Corporation (SHE:300261)
China
· Delayed Price · Currency is CNY 5.96
0.00 (0.00%)
Apr 29, 2026, 3:04 PM CST
ABA Chemicals Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | 2021 - 2017 |
| Operating Revenue | 1,307 | 1,168 | 1,224 | 1,887 | 1,987 | Upgrade
|
| Other Revenue | - | 33.89 | 54.83 | 114.15 | 84.81 | Upgrade
|
| Revenue | 1,307 | 1,202 | 1,279 | 2,001 | 2,072 | Upgrade
|
| Revenue Growth (YoY) | 8.73% | -6.00% | -36.09% | -3.42% | 3.42% | Upgrade
|
| Cost of Revenue | 1,067 | 1,066 | 1,000 | 1,401 | 1,500 | Upgrade
|
| Gross Profit | 240.6 | 135.78 | 278.48 | 599.68 | 571.9 | Upgrade
|
| Selling, General & Admin | 171.62 | 184.82 | 193.6 | 192.45 | 201.45 | Upgrade
|
| Research & Development | 116.74 | 120.02 | 117.65 | 130.37 | 123.23 | Upgrade
|
| Other Operating Expenses | 1.97 | 4.15 | 11.68 | 13.37 | 12.58 | Upgrade
|
| Operating Expenses | 290.33 | 315.05 | 346.38 | 349.26 | 338.95 | Upgrade
|
| Operating Income | -49.73 | -179.27 | -67.9 | 250.42 | 232.94 | Upgrade
|
| Interest Expense | - | -34.42 | -34.57 | -38.1 | -41.3 | Upgrade
|
| Interest & Investment Income | - | 10.24 | 15.82 | 3.7 | 3.83 | Upgrade
|
| Currency Exchange Gain (Loss) | - | 4.54 | 12.96 | 51.51 | -13.78 | Upgrade
|
| Other Non Operating Income (Expenses) | -70.98 | -4.48 | 0.08 | -1.01 | -0.9 | Upgrade
|
| EBT Excluding Unusual Items | -120.7 | -203.41 | -73.61 | 266.52 | 180.8 | Upgrade
|
| Impairment of Goodwill | - | -106.04 | -42.52 | - | - | Upgrade
|
| Gain (Loss) on Sale of Investments | -25.19 | -4.25 | 28.52 | -25.14 | 34.66 | Upgrade
|
| Gain (Loss) on Sale of Assets | 0.16 | 0.3 | 3.83 | 0.93 | -0.17 | Upgrade
|
| Asset Writedown | -52.41 | -0.36 | -0.08 | -0.21 | -1.89 | Upgrade
|
| Other Unusual Items | - | 4.84 | -4.95 | 2.41 | 5.25 | Upgrade
|
| Pretax Income | -198.14 | -308.91 | -88.82 | 244.51 | 218.65 | Upgrade
|
| Income Tax Expense | -13.56 | -44.78 | -16.46 | 24.97 | 23.13 | Upgrade
|
| Earnings From Continuing Operations | -184.58 | -264.13 | -72.36 | 219.53 | 195.51 | Upgrade
|
| Minority Interest in Earnings | 25.07 | 6.43 | -9.93 | -16.59 | -13.66 | Upgrade
|
| Net Income | -159.51 | -257.7 | -82.29 | 202.95 | 181.85 | Upgrade
|
| Net Income to Common | -159.51 | -257.7 | -82.29 | 202.95 | 181.85 | Upgrade
|
| Net Income Growth | - | - | - | 11.60% | 12.94% | Upgrade
|
| Shares Outstanding (Basic) | 956 | 955 | 955 | 955 | 955 | Upgrade
|
| Shares Outstanding (Diluted) | 956 | 955 | 955 | 955 | 955 | Upgrade
|
| Shares Change (YoY) | 0.09% | 0.01% | 0.01% | 0.00% | -0.28% | Upgrade
|
| EPS (Basic) | -0.17 | -0.27 | -0.09 | 0.21 | 0.19 | Upgrade
|
| EPS (Diluted) | -0.17 | -0.27 | -0.09 | 0.21 | 0.19 | Upgrade
|
| EPS Growth | - | - | - | 11.60% | 13.26% | Upgrade
|
| Free Cash Flow | -128.4 | 57.54 | -258.13 | -108.89 | 331.48 | Upgrade
|
| Free Cash Flow Per Share | -0.13 | 0.06 | -0.27 | -0.11 | 0.35 | Upgrade
|
| Dividend Per Share | - | 0.050 | - | 0.050 | - | Upgrade
|
| Gross Margin | 18.41% | 11.29% | 21.77% | 29.97% | 27.61% | Upgrade
|
| Operating Margin | -3.80% | -14.91% | -5.31% | 12.52% | 11.24% | Upgrade
|
| Profit Margin | -12.20% | -21.44% | -6.44% | 10.14% | 8.78% | Upgrade
|
| Free Cash Flow Margin | -9.82% | 4.79% | -20.18% | -5.44% | 16.00% | Upgrade
|
| EBITDA | 89.48 | -45.84 | 65.64 | 382.02 | 359.14 | Upgrade
|
| EBITDA Margin | 6.84% | -3.81% | 5.13% | 19.09% | 17.34% | Upgrade
|
| D&A For EBITDA | 139.21 | 133.43 | 133.54 | 131.6 | 126.2 | Upgrade
|
| EBIT | -49.73 | -179.27 | -67.9 | 250.42 | 232.94 | Upgrade
|
| EBIT Margin | -3.80% | -14.91% | -5.31% | 12.52% | 11.24% | Upgrade
|
| Effective Tax Rate | - | - | - | 10.21% | 10.58% | Upgrade
|
| Revenue as Reported | - | 1,202 | 1,279 | 2,001 | 2,072 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.